IRWD: Ironwood Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 121.36
Enterprise Value ($M) 616.79
Book Value ($M) -301.25
Book Value / Share -1.86
Price / Book -0.40
NCAV ($M) -470.13
NCAV / Share -2.91
Price / NCAV -0.26

Profitability (mra)
Return on Invested Capital (ROIC) 0.01
Return on Assets (ROA) 0.00
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 4.66
Current Ratio 4.66

Balance Sheet (mrq) ($M)
Current Assets 182.42
Assets 351.30
Liabilities 652.54
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 351.41
Operating Income 97.44
Net Income 1.81
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 103.55
Cash from Investing -0.14
Cash from Financing -106.97

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-07 13G/A BlackRock, Inc. 7.10 -50.76
02-14 13G/A Armistice Capital, Llc 5.92 15.46
02-05 13G State Street Corp 5.20 -16.04
01-31 13G/A Vanguard Group Inc 12.20 -11.34
11-13 13G Renaissance Technologies Llc 5.37

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-31 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 406,802 3,093,251 13.15
2025-04-16 985,421 5,899,766 16.70
2025-04-15 2,756,493 13,266,463 20.78
2025-04-14 4,680,477 15,028,292 31.14

(click for more detail)

Similar Companies
IOBT – IO Biotech, Inc. IONS – Ionis Pharmaceuticals, Inc.
IPSC – Century Therapeutics, Inc. JAZZ – Jazz Pharmaceuticals plc
KMDA – Kamada Ltd.


Financial data and stock pages provided by
Fintel.io